Literature DB >> 35177120

Comparing different machine learning techniques for predicting COVID-19 severity.

Yibai Xiong1, Yan Ma1, Lianguo Ruan2, Dan Li3, Cheng Lu4, Luqi Huang5.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is still ongoing spreading globally, machine learning techniques were used in disease diagnosis and to predict treatment outcomes, which showed favorable performance. The present study aims to predict COVID-19 severity at admission by different machine learning techniques including random forest (RF), support vector machine (SVM), and logistic regression (LR). Feature importance to COVID-19 severity were further identified.
METHODS: A retrospective design was adopted in the JinYinTan Hospital from January 26 to March 28, 2020, eighty-six demographic, clinical, and laboratory features were selected with LassoCV method, Spearman's rank correlation, experts' opinions, and literature evaluation. RF, SVM, and LR were performed to predict severe COVID-19, the performance of the models was compared by the area under curve (AUC). Additionally, feature importance to COVID-19 severity were analyzed by the best performance model.
RESULTS: A total of 287 patients were enrolled with 36.6% severe cases and 63.4% non-severe cases. The median age was 60.0 years (interquartile range: 49.0-68.0 years). Three models were established using 23 features including 1 clinical, 1 chest computed tomography (CT) and 21 laboratory features. Among three models, RF yielded better overall performance with the highest AUC of 0.970 than SVM of 0.948 and LR of 0.928, RF also achieved a favorable sensitivity of 96.7%, specificity of 69.5%, and accuracy of 84.5%. SVM had sensitivity of 93.9%, specificity of 79.0%, and accuracy of 88.5%. LR also achieved a favorable sensitivity of 92.3%, specificity of 72.3%, and accuracy of 85.2%. Additionally, chest-CT had highest importance to illness severity, and the following features were neutrophil to lymphocyte ratio, lactate dehydrogenase, and D-dimer, respectively.
CONCLUSIONS: Our results indicated that RF could be a useful predictive tool to identify patients with severe COVID-19, which may facilitate effective care and further optimize resources.
© 2022. The Author(s).

Entities:  

Keywords:  COVID-19; Logistic regression; Machine learning; Random Forest; Severity; Support vector machine

Mesh:

Year:  2022        PMID: 35177120      PMCID: PMC8851750          DOI: 10.1186/s40249-022-00946-4

Source DB:  PubMed          Journal:  Infect Dis Poverty        ISSN: 2049-9957            Impact factor:   4.520


Background

Coronavirus disease 2019 (COVID-19) has been a severe public health event and is still ongoing spreading globally [1, 2]. The main manifestations of COVID-19 include fever, fatigue, and dry cough, most COVID-19 cases are non-severe with favorable outcome [3, 4]. However, patients with severe COVID-19 tend to progress rapidly and experience respiratory failure, respiratory distress syndrome, and septic shock or even death within a short period of time [5], with a high mortality of 53% [6]. Previous studies observed that male, aged over 65, smoking, elevated lactate dehydrogenase, elevated D-dimer, and chest imaging findings associated with COVID-19 severity [7-10]. However, the studies didn’t demonstrate indicators’ contribution to COVID-19 severity on admission. Hence, it is essential to assess importance of features to disease severity on admission for earlier and more targeted care, further reduce severe disease and prioritize medical resource. Machine learning as an effective and innovative tool has been reported applications in diabetes [11], cardiovascular diseases [12], cancer [13, 14], sepsis [15], and depression [16], etc., and showed favorable performance. Moreover, machine learning was used to predict COVID-19 diagnosis and treatment outcome, etc. [17-21]. However, different machine learning techniques were used to predict COVID-19 severity have not well been reported. Our study aimed to compare different machine learning techniques including random forest (RF), support vector machine (SVM), and logistic regression (LR) to predict COVID-19 severity based on clinical, laboratory, and chest computed tomography (C-CT) features, further identify feature importance to COVID-19 severity. The results can provide reference for clinicians to diagnose and treat patients timely and effectively, and further optimize medical resources, especially in resource-limited areas.

Methods

Study design and participants

A retrospective study was conducted in the JinYinTan Hospital from January 26 to March 28, 2020. Data of demographic, clinical, laboratory, C-CT features, and treatment outcome were reviewed from 287 patients of hospital information system, all cases were laboratory-confirmed by real-time reverse transcriptase polymerase chain reaction assay.

Feature selection

In the present study, 30 features were remained after the initial 86 features were screened by LassoCV in the study. Subsequently, we carried out spearman’s rank correlation to further reduce confounding, features with correlation coefficients greater than 0.4 (r > 0.4)were excluded. For example, white blood cell (WBC) was correlated with neutrophil to lymphocyte ratio (NLR); red blood cell (RBC) and hematocrit (HCT) were both correlated with hemoglobin concentration (HB); albumin (ALB) is associated with cholinesterase (CHE), etc. Additionally, combined with expert opinions, and literature evaluation 7 features were excluded from 30 features, namely WBC, RBC, HCT, ALB, r-glutamyl transpeptidase(r-GT), CHE, creatine kinase (CK), then 23 features were remained (Fig. 1), correlation coefficient between features were less than 0.4 (Fig.2), which were entered into models for further analysis.
Fig. 1

Flow chart of feature selection. WBC White blood cell, RBC red blood cell, ALB albumin, r-GT r-glutamyl transpeptidase, CHE cholinesterase, HCT hematocrit, CK creatine kinase

Fig. 2

The heat map of correlation between features. Color indicates the value of the correlation coefficient (r). The color intensity is proportional to the correlation coefficient (r), with positive correlations (r > 0) shown and negative correlations (r < 0), lower intensive color indicates lower correlations, in the study, 23 features selected by machine learning techniques, each feature is weakly correlated with each other (r < 0.4). Twenty-three features including C-CT, fever, MT, HR, SBP, HB, NLR, RDW-CV, IMG, IL-6, ESR, IBIL, ALP CysC, LDH, Ca2+, AFU, AMS, RBP, Hs-cTn, MB, PT(s), D-dimer. C-CT chest computed tomography, MT malignant tumor, HR heart rate, SBP systolic blood pressure, NLR neutrophil-to-lymphocyte ratio, HB hemoglobin concentration, RDW-CV red cell volume distribution width, LDH lactate dehydrogenase, IBIL indirect bilirubin, PT prothrombin time, ESR erythrocyte sedimentation rate, AFU α-fucosidase, RBP retinol-Binding protein, IL-6 interleukin-6, Hs-cTn hypersensitive troponin, AMS amylase, CysC cystatin C, IMG immature granulocyte, ALP alkaline phosphatas, MB myoglobin

Flow chart of feature selection. WBC White blood cell, RBC red blood cell, ALB albumin, r-GT r-glutamyl transpeptidase, CHE cholinesterase, HCT hematocrit, CK creatine kinase The heat map of correlation between features. Color indicates the value of the correlation coefficient (r). The color intensity is proportional to the correlation coefficient (r), with positive correlations (r > 0) shown and negative correlations (r < 0), lower intensive color indicates lower correlations, in the study, 23 features selected by machine learning techniques, each feature is weakly correlated with each other (r < 0.4). Twenty-three features including C-CT, fever, MT, HR, SBP, HB, NLR, RDW-CV, IMG, IL-6, ESR, IBIL, ALP CysC, LDH, Ca2+, AFU, AMS, RBP, Hs-cTn, MB, PT(s), D-dimer. C-CT chest computed tomography, MT malignant tumor, HR heart rate, SBP systolic blood pressure, NLR neutrophil-to-lymphocyte ratio, HB hemoglobin concentration, RDW-CV red cell volume distribution width, LDH lactate dehydrogenase, IBIL indirect bilirubin, PT prothrombin time, ESR erythrocyte sedimentation rate, AFU α-fucosidase, RBP retinol-Binding protein, IL-6 interleukin-6, Hs-cTn hypersensitive troponin, AMS amylase, CysC cystatin C, IMG immature granulocyte, ALP alkaline phosphatas, MB myoglobin Twenty-three features included chest computed tomography (C-CT), fever, malignant tumor(MT), heart rate (HR), systolic blood pressure (SBP), hemoglobin concentration (HB), neutrophil-to-lymphocyte ratio (NLR), red cell volume distribution width (RDW-CV), immature granulocyte (IMG), interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), indirect bilirubin (IBIL), alkaline phosphatas (ALP), cystatin C (CysC), lactate dehydrogenase (LDH), Ca2+, α-fucosidase (AFU), amylase (AMS), retinol-Binding protein (RBP), hypersensitive troponin (Hs-cTn), myoglobin (MB), prothrombin time (PT), D-dimer.

Features and models

Both dichotomous features are containing precisely two distinct values in the form of 0 and 1, for the three classification features such as C-CT, 0, 1 and 2 as three categorical variables were used to represent no lesions, unilateral lesions, and bilateral lesions, respectively; continuous variables were expressed with unit standardization. The 23 features were processed by RF, SVM, and LR modeling to compare the three models in predicting COVID-19 severity on admission. RF is a classifier that contains multiple decision trees, and the output is determined by the voting results of multiple trees. We used a grid search method to determine the number of classifiers, maximum depth, and minimum number of branch samples in random forest modeling. SVM based on statistical learning theory, is a class of generalized linear classification technique that classifies data binary in a supervised learning manner, and correctly classifies samples by looking for decision boundaries. LR is a generalized linear regression analysis model that uses different kernel functions to estimate data conditions. Similar to random forest, we use grid search method to determine the selection of key parameters of SVM and LR, thereby reducing the training error in modeling.

COVID-19 severity for prediction

COVID-19 severity was determined based on the Diagnosis and Treatment Protocol for COVID-19 (seventh edition) [22]. In our study, given the small sample of 287 patients analyzed from single center, therefore, COVID-19 cases were categorized as non-severe and severe cases. Mild and moderate cases were classified as non-severe cases, severe and critical were classified as severe cases. The outcome variable was coded as binary 0 or 1, and the predictive output variable was defined as severe type (coded as 1) and non-severe type (coded as 0).

Model training and generalization

Of three models, 10-fold cross-validation was used to determine best appropriate data set to further better accuracy on predictions. Firstly, we split the all data into 10 number of folds. Each model has been trained and tested 10 times. For every iteration we selected 1-fold as test data and rest all as training data and ensured that different sets of data were used for model training and testing each time. Finally, we summed up the score for every fold and took the average to get the overall score.

Evaluation of model performance

The model’s performance was evaluated respectively to compare the sensitivity, specificity, accuracy and area under curve (AUC) of receiver operating characteristic (ROC) of different models for severe COVID-19. The cut-off value was determined by the point on ROC curve where the Youden index was highest.

Importance of test types

In order to quantify the importance of clinical, laboratory, and C-CT features on the predicted outcomes, the best performance model was used to provide relative feature importance by computing the contribution of each input feature toward the predictive outcome.

Statistical analysis

Categorical and continuous variables were expressed as n (%) and median (interquartile range, IQR), respectively. The Mann Whitney U test, χ2 test, or Fisher’s exact test were used to compare differences between severe and non-severe cases, as appropriately. The LR, SVM, and RF models were all performed, and AUC were calculated by using python 3.8.3 (Python Software Foundation, Delaware, USA) and anaconda 4.10.1 (Red Hat, Raleigh, North Carolina, USA). Main python module was shown in Additional file 1.

Results

Cohort characteristics

A total of 287 patients enrolled in our study. The median age was 60.0 years (IQR: 49.0–68.0 years) with 63.0 years (IQR: 55.5–70.0 years) for severe cases and 57.0 years (IQR: 46.7–67.0 years) for non-severe cases. A higher proportion (56.4%) was male, and the proportion of severe and non-severe cases were 36.6% and 63.4%, respectively. The most common symptoms reported were cough (61.3%) and fever (30.7%), 23 features of COVID-19 patients in the cohort are demonstrated in Table 1.
Table 1

Twenty-three features of COVID-19 patients in the cohort

VariablesAll casesNon-severe casesSevere casesP
(n = 287)(n = 182)(n = 105)
Fever88 (30.7)57 (31.3)31 (29.5)0.751
MT16 (5.6)11 (6.0)5 (4.8)0.648
HR, beats/min88 (80–99)87 (80–98)88 (84–99)0.122
SBP, mmHg127 (117–138)125 (115–136)131 (121–138)0.008
Laboratory findings
 NLR3.28 (2.17–5.77)2.71 (1.70–4.15)5.73 (3.17–9.97) < 0.001
 HB127.0 (117.0–136.0)128.0 (119.0–136.0)123 (114.0–136.0)0.109
 RDW-CV12.4 (11.9–12.9)12.3 (11.9–12.8)12.5 (11.9–13.0)0.032
 LDH258.0 (200.0–346.5)231.0 (184.7–276.5)343.0 (261.0–452.0) < 0.001
 IBIL8.4 (6.1–11.6)8.9 (6.6–11.8)7.8 (5.6–10.80)0.048
 D-Dimer0.7 (0.4–1.5)0.5 (0.3–0.9)1.1 (0.6–1.5) < 0.001
 PT11.3 (10.7–12.0)11.2 (10.6–11.7)11.7 (10.8–12.6) < 0.001
 Ca2+2.10 (1.99–2.17)2.09 (22.0–52.25)2.01 (1.93–2.10) < 0.001
 ESR43.0 ( (26.0–58.0)40.5 (18.0–27.0)50.3 (35.0–65.5) < 0.001
 AFU23.0 (19.0–27.0)23.0 (18.0–27.0)23.0 (20.0–27.0)0.508
 RBP26.4 (19.0–40.4)26.4 (20.6–40.5)26.4 (17.1–40.0)0.433
 IL-68.3 (6.5–11.7)8.2 (6.5–10.2)9.2 (7.2–12.9)0.001
 Hs-cTn3.6 (1.5–8.3)2.9 (1.1–5.8)6.2 (2.8–12.4) < 0.001
 AMS62.0 (49.0–79.5)62.0 (49.3–74.0)68.0 (49.0–97.0)0.078
 CysC0.85 (0.75–1.03)0.83 (0.73–0.94)0.95 (0.78–1.16) < 0.001
 IMG0.01 (0.01–0.04)0.01 (0.00–0.03)0.03 (0.01–0.11) < 0.001
 ALP76.0 (59.5–94.0)76.0 (59.3–95.8)75.0 (60.0–93.0)0.806
 MB42.4 (30.7–64.5)39.1 (28.0–53.0)50.1 (38.8–87.3) < 0.001
C-CTa < 0.001
 063 (22.0%)63 (34.6%)0 (0%)
 129 (10.1%)23 (12.6%)6 (5.7%)
 2195 (67.9%)96 (52.7%)99 (94.3%)

Data were presented median (IQR) or n (%). P values were estimated by comparing variables between severe and non-severe cases

a“0” denotes” no lung lesions”, “1” denotes “unilateral lung lesions”, and “2” denotes “bilateral lung lesions”

MT Malignant tumor, HR Heart rate, SBP Systolic blood pressure, NLR Neutrophil-to-lymphocyte ratio, HB Hemoglobin concentration, RDW-CV Red cell volume distribution width, LDH Lactate dehydrogenase, IBIL Indirect bilirubin, PT Prothrombin time, ESR Erythrocyte sedimentation rate, AFU α-fucosidase, RBP Retinol-Binding protein, IL-6 Interleukin-6, Hs-cTn Hypersensitive troponin, AMS Amylase, CysC cystatin C, IMG Immature granulocyte, ALP Alkaline phosphatas, MB Myoglobin, C-CT Chest computed tomography

Twenty-three features of COVID-19 patients in the cohort Data were presented median (IQR) or n (%). P values were estimated by comparing variables between severe and non-severe cases a“0” denotes” no lung lesions”, “1” denotes “unilateral lung lesions”, and “2” denotes “bilateral lung lesions” MT Malignant tumor, HR Heart rate, SBP Systolic blood pressure, NLR Neutrophil-to-lymphocyte ratio, HB Hemoglobin concentration, RDW-CV Red cell volume distribution width, LDH Lactate dehydrogenase, IBIL Indirect bilirubin, PT Prothrombin time, ESR Erythrocyte sedimentation rate, AFU α-fucosidase, RBP Retinol-Binding protein, IL-6 Interleukin-6, Hs-cTn Hypersensitive troponin, AMS Amylase, CysC cystatin C, IMG Immature granulocyte, ALP Alkaline phosphatas, MB Myoglobin, C-CT Chest computed tomography

Predictive performance

We further analyzed the predictive performance of RF, SVM and LR with AUC, sensitivity, specificity, and accuracy (Table 2, Fig. 3), in terms of predictive performance among the three models, we observed that the overall better performance by AUC of 0.970 were RF for predicting COVID-19 severity at admission compared to SVM with AUC of 0.948 and LR with AUC of 0.928. Moreover, RF also achieved a favorable sensitivity of 96.7%, specificity of 69.5%, and accuracy of 84.5%. SVM had sensitivity of 93.9%, specificity of 79.0%, and accuracy of 88.5%. LR model had sensitivity of 92.3%, specificity of 72.3%, and accuracy of 85.2%.
Table 2

Predictive performance for COVID-19 severity

ModelAUCSensitivity (%)Specificity (%)Accuracy (%)Cut offYI
RF0.97096.769.584.50.620.662
SVM0.94893.979.088.50.7950.729
LR0.92892.372.385.20.570.646

AUC area under curve, YI youden index, RF random Forest, SVM support vector machine, LR logistic regression

Fig. 3

ROC curves of RF, SVM, and LR. ROC receiver operating characteristic, AUC area under curve, RF random forest, SVM support vector machine, LR logistic regression

Predictive performance for COVID-19 severity AUC area under curve, YI youden index, RF random Forest, SVM support vector machine, LR logistic regression ROC curves of RF, SVM, and LR. ROC receiver operating characteristic, AUC area under curve, RF random forest, SVM support vector machine, LR logistic regression

Feature importance

We further analyzed the top 23 features ranked by relative importance to COVID-19 severity by using RF with best performance. C-CT had highest importance to COVID-19 severity, and the following were NLR, LDH count, and D-Dimer, respectively (Fig. 4).
Fig. 4

Feature importance: The top 23 features ranked by relative importance to COVID-19 severity by RF. C-CT chest computed tomography, MT malignant tumor, HR heart rate, SBP systolic blood pressure, NLR neutrophil-to-lymphocyte ratio, HB hemoglobin concentration, RDW-CV red cell volume distribution width, LDH lactate dehydrogenase, IBIL indirect bilirubin, PT prothrombin time, ESR erythrocyte sedimentation rate, AFU α-fucosidase, RBP retinol-binding protein, IL-6 interleukin-6, Hs-cTn hypersensitive troponin, AMS amylase, CysC cystatin C, IMG immature granulocyte, ALP alkaline phosphatas, MB myoglobin

Feature importance: The top 23 features ranked by relative importance to COVID-19 severity by RF. C-CT chest computed tomography, MT malignant tumor, HR heart rate, SBP systolic blood pressure, NLR neutrophil-to-lymphocyte ratio, HB hemoglobin concentration, RDW-CV red cell volume distribution width, LDH lactate dehydrogenase, IBIL indirect bilirubin, PT prothrombin time, ESR erythrocyte sedimentation rate, AFU α-fucosidase, RBP retinol-binding protein, IL-6 interleukin-6, Hs-cTn hypersensitive troponin, AMS amylase, CysC cystatin C, IMG immature granulocyte, ALP alkaline phosphatas, MB myoglobin

Discussion

Previous studies observed that RF, LR, SVM, gradient boosted decision tree, and neural network to predict COVID-19 [23-25]. Schwab et al. demonstrated that RF had highest predictive performance for predicting hospital admissions for COVID-19 patients, and critical care admissions for COVID-19 cases in terms of AUC compared to LR, SVM, neural network, and gradient boosting [25]. In the present study, we found that RF could predict COVID-19 severity with best performance compared to SVM and LR. The results highlight the possibility that high-performance of RF are able to predict disease severity, the findings can provide reference to monitor parameters effectively and further optimize medical resource. Chest CT is a widely used imaging test, which can be useful for initial triage of suspected COVID-19 patients. Previous studies demonstrated that chest CT or X-rays findings were associated with COVID-19 severity based on machine learning [26-30], our data observed that chest CT findings with highest importance scores was for diagnosis of severe COVID-19 on admission by RF model, which can help clinicians a fast diagnosis and severity assessment of COVID-19 even before molecular test results are available or laboratory testing is limited. Wang et al. reported that COVID-19 clinical severity could be assessed based on the proposed chest lung-lesion automated deep-learning model [26], given deep learning was likely to be over-fitting for small sample, therefore, which was not used in the study. Following the C-CT ranked feature importance scores were NLR, LDH, D-Dimer, Ca2+, ESR, and AFU, respectively, were confirmed in previous studies [30-32]. Ponti et al. reported that NLR was closely in relationship with coagulation cascades in disseminated intravascular coagulation and acute respiratory distress syndrome in severe COVID-19 patients [33]. LDH and D-dimer are consistently reported among hospitalized severe COVID-19 patients [7], while gradual development during the disease course is particularly related to disease worsening in adults and children [34, 35]. However, compared with previous researches, AFU and HB are rarely mentioned in COVID-19 severity. AFU is essential in viral and bacterial infections including the cell-cell adhesion processes that mediate inflammation [36, 37]. Studies illustrated that AFU may be potentially upregulated by chemokines in the later stages of inflammation, such as COVID-19 [37, 38]. We also found that AFU is a significant lab indicator to distinguish severe illness, which may be a possible therapeutic target in the future. In other studies, hemoglobin and red blood cell count were found lower in COVID-19 patients, however, with no significant difference between survivors and non-survivors [39]. COVID-19 patients might suffer from hyper-metabolic states, such as septic shock and multiple organ dysfunction syndromes, which needs an increasing capability of hemoglobin to support the peripheral tissue demands for oxygen [40]. The ability to meet the oxygen demands of the peripheral tissues caused by the COVID-19 infection becomes the leading role to decide the prognosis, according to recent evidence [41]. Our study has several limitations. Firstly, the small sample size from a single study site is a major limitation of the present study, which may undermine reliability of our analysis. Secondly, the data was retrospective collected, some data were incomplete or missing (such as smoking and drinking, and educational level), which were not further analyzed in the study. Further large sample, multi-center studies should be conducted to confirm our results.

Conclusions

Our study indicates that RF may be a prioritization tool in predicting COVID-19 severity with favorable overall performance at admission. The prediction model can potentially assist clinicians to facilitate severe COVID-19 patients’ identification promptly and apply treatment timely, further optimize potentially healthcare resources. Additional file 1. Main python module.
  41 in total

1.  Development of a UHPLC-MS method for inhibitor screening against α-L-1,3-fucosidase.

Authors:  Tangrong Liu; Ruonan Liu; Li Zhu; Xuan Zou; Huashi Guan; Zhe Xu
Journal:  Anal Bioanal Chem       Date:  2019-02-01       Impact factor: 4.142

2.  Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7).

Authors: 
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

3.  Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.

Authors:  Jingyuan Liu; Yao Liu; Pan Xiang; Lin Pu; Haofeng Xiong; Chuansheng Li; Ming Zhang; Jianbo Tan; Yanli Xu; Rui Song; Meihua Song; Lin Wang; Wei Zhang; Bing Han; Li Yang; Xiaojing Wang; Guiqin Zhou; Ting Zhang; Ben Li; Yanbin Wang; Zhihai Chen; Xianbo Wang
Journal:  J Transl Med       Date:  2020-05-20       Impact factor: 5.531

4.  Using Artificial Intelligence to Detect COVID-19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy.

Authors:  Lin Li; Lixin Qin; Zeguo Xu; Youbing Yin; Xin Wang; Bin Kong; Junjie Bai; Yi Lu; Zhenghan Fang; Qi Song; Kunlin Cao; Daliang Liu; Guisheng Wang; Qizhong Xu; Xisheng Fang; Shiqin Zhang; Juan Xia; Jun Xia
Journal:  Radiology       Date:  2020-03-19       Impact factor: 11.105

5.  Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.

Authors:  Zhaohai Zheng; Fang Peng; Buyun Xu; Jingjing Zhao; Huahua Liu; Jiahao Peng; Qingsong Li; Chongfu Jiang; Yan Zhou; Shuqing Liu; Chunji Ye; Peng Zhang; Yangbo Xing; Hangyuan Guo; Weiliang Tang
Journal:  J Infect       Date:  2020-04-23       Impact factor: 6.072

6.  Using machine learning of clinical data to diagnose COVID-19: a systematic review and meta-analysis.

Authors:  Wei Tse Li; Jiayan Ma; Neil Shende; Grant Castaneda; Jaideep Chakladar; Joseph C Tsai; Lauren Apostol; Christine O Honda; Jingyue Xu; Lindsay M Wong; Tianyi Zhang; Abby Lee; Aditi Gnanasekar; Thomas K Honda; Selena Z Kuo; Michael Andrew Yu; Eric Y Chang; Mahadevan Raj Rajasekaran; Weg M Ongkeko
Journal:  BMC Med Inform Decis Mak       Date:  2020-09-29       Impact factor: 2.796

7.  Machine learning based early warning system enables accurate mortality risk prediction for COVID-19.

Authors:  Yue Gao; Guang-Yao Cai; Wei Fang; Hua-Yi Li; Si-Yuan Wang; Lingxi Chen; Yang Yu; Dan Liu; Sen Xu; Peng-Fei Cui; Shao-Qing Zeng; Xin-Xia Feng; Rui-Di Yu; Ya Wang; Yuan Yuan; Xiao-Fei Jiao; Jian-Hua Chi; Jia-Hao Liu; Ru-Yuan Li; Xu Zheng; Chun-Yan Song; Ning Jin; Wen-Jian Gong; Xing-Yu Liu; Lei Huang; Xun Tian; Lin Li; Hui Xing; Ding Ma; Chun-Rui Li; Fei Ye; Qing-Lei Gao
Journal:  Nat Commun       Date:  2020-10-06       Impact factor: 14.919

8.  Model-based Prediction of Critical Illness in Hospitalized Patients with COVID-19.

Authors:  Steven Schalekamp; Merel Huisman; Rogier A van Dijk; Martijn F Boomsma; Pedro J Freire Jorge; Wytze S de Boer; Gerada Judith M Herder; Marja Bonarius; Oscar A Groot; Eefje Jong; Anton Schreuder; Cornelia M Schaefer-Prokop
Journal:  Radiology       Date:  2020-08-13       Impact factor: 11.105

9.  Hematological findings and complications of COVID-19.

Authors:  Evangelos Terpos; Ioannis Ntanasis-Stathopoulos; Ismail Elalamy; Efstathios Kastritis; Theodoros N Sergentanis; Marianna Politou; Theodora Psaltopoulou; Grigoris Gerotziafas; Meletios A Dimopoulos
Journal:  Am J Hematol       Date:  2020-05-23       Impact factor: 13.265

10.  Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal

Authors:  Laure Wynants; Ben Van Calster; Gary S Collins; Richard D Riley; Georg Heinze; Ewoud Schuit; Marc M J Bonten; Darren L Dahly; Johanna A A Damen; Thomas P A Debray; Valentijn M T de Jong; Maarten De Vos; Paul Dhiman; Maria C Haller; Michael O Harhay; Liesbet Henckaerts; Pauline Heus; Michael Kammer; Nina Kreuzberger; Anna Lohmann; Kim Luijken; Jie Ma; Glen P Martin; David J McLernon; Constanza L Andaur Navarro; Johannes B Reitsma; Jamie C Sergeant; Chunhu Shi; Nicole Skoetz; Luc J M Smits; Kym I E Snell; Matthew Sperrin; René Spijker; Ewout W Steyerberg; Toshihiko Takada; Ioanna Tzoulaki; Sander M J van Kuijk; Bas van Bussel; Iwan C C van der Horst; Florien S van Royen; Jan Y Verbakel; Christine Wallisch; Jack Wilkinson; Robert Wolff; Lotty Hooft; Karel G M Moons; Maarten van Smeden
Journal:  BMJ       Date:  2020-04-07
View more
  6 in total

Review 1.  A Comprehensive Review of Machine Learning Used to Combat COVID-19.

Authors:  Rahul Gomes; Connor Kamrowski; Jordan Langlois; Papia Rozario; Ian Dircks; Keegan Grottodden; Matthew Martinez; Wei Zhong Tee; Kyle Sargeant; Corbin LaFleur; Mitchell Haley
Journal:  Diagnostics (Basel)       Date:  2022-07-31

2.  Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study.

Authors:  Daniel Chober; Bogusz Aksak-Wąs; Katarzyna Bobrek-Lesiakowska; Anna Budny-Finster; Ewa Hołda; Joanna Mieżyńska-Kurtycz; Grzegorz Jamro; Miłosz Parczewski
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.241

3.  Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression.

Authors:  Liam Townsend; Adam H Dyer; Aifric Naughton; Sultan Imangaliyev; Jean Dunne; Rachel Kiersey; Dean Holden; Aoife Mooney; Deirdre Leavy; Katie Ridge; Jamie Sugrue; Mubarak Aldoseri; Jo Hannah Kelliher; Martina Hennessy; Declan Byrne; Paul Browne; Christopher L Bacon; Catriona Doyle; Ruth O'Riordan; Anne-Marie McLaughlin; Ciaran Bannan; Ignacio Martin-Loeches; Arthur White; Rachel M McLoughlin; Colm Bergin; Nollaig M Bourke; Cliona O'Farrelly; Niall Conlon; Clíona Ní Cheallaigh
Journal:  Heliyon       Date:  2022-04-01

4.  Multi-region machine learning-based novel ensemble approaches for predicting COVID-19 pandemic in Africa.

Authors:  Zurki Ibrahim; Pinar Tulay; Jazuli Abdullahi
Journal:  Environ Sci Pollut Res Int       Date:  2022-08-11       Impact factor: 5.190

5.  A machine learning model on Real World Data for predicting progression to Acute Respiratory Distress Syndrome (ARDS) among COVID-19 patients.

Authors:  Nicola Lazzarini; Avgoustinos Filippoupolitis; Pedro Manzione; Hariklia Eleftherohorinou
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

6.  Assessing the Nationwide COVID-19 Risk in Mexico through the Lens of Comorbidity by an XGBoost-Based Logistic Regression Model.

Authors:  Sonia Venancio-Guzmán; Alejandro Ivan Aguirre-Salado; Carlos Soubervielle-Montalvo; José Del Carmen Jiménez-Hernández
Journal:  Int J Environ Res Public Health       Date:  2022-09-22       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.